ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,254.18
-0.76%
Dow Jones
38,785.17
-0.73%
Gold vs US Dollar
2,358.17
0.27%
Brent Oil
84.28
1.73%
Bitcoin
68,310.61
-1.56%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Athira Pharma Inc (ATHA)

  7. Athira Pharma Inc (ATHA) News

Athira Pharma (ATHA)

Athira Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATHA
DateTimeSourceHeadlineSymbolCompany
25/05/202400:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
24/05/202423:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
24/05/202423:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
17/05/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHAAthira Pharma Inc
17/05/202422:00GlobeNewswire Inc.Athira Pharma Announces Proposed Settlement of Stockholder Derivative ActionNASDAQ:ATHAAthira Pharma Inc
15/05/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHAAthira Pharma Inc
15/05/202421:05GlobeNewswire Inc.Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business UpdatesNASDAQ:ATHAAthira Pharma Inc
02/05/202412:00GlobeNewswire Inc.Athira Pharma to Participate in Upcoming May ConferencesNASDAQ:ATHAAthira Pharma Inc
15/04/202412:00GlobeNewswire Inc.Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical OfficerNASDAQ:ATHAAthira Pharma Inc
11/04/202412:00GlobeNewswire Inc.Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s DiseaseNASDAQ:ATHAAthira Pharma Inc
03/04/202412:00GlobeNewswire Inc.Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual MeetingNASDAQ:ATHAAthira Pharma Inc
08/03/202412:00GlobeNewswire Inc.Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International ConferenceNASDAQ:ATHAAthira Pharma Inc
22/02/202421:34Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ATHAAthira Pharma Inc
22/02/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHAAthira Pharma Inc
22/02/202421:05GlobeNewswire Inc.Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business UpdatesNASDAQ:ATHAAthira Pharma Inc
16/02/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
16/02/202421:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
16/02/202421:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
16/02/202421:40Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ATHAAthira Pharma Inc
16/02/202421:37Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ATHAAthira Pharma Inc
16/02/202421:32Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ATHAAthira Pharma Inc
08/02/202421:02GlobeNewswire Inc.Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)NASDAQ:ATHAAthira Pharma Inc
08/01/202421:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
08/01/202421:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
08/01/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
08/01/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
08/01/202421:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
08/01/202412:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHAAthira Pharma Inc
08/01/202412:00GlobeNewswire Inc.Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business UpdateNASDAQ:ATHAAthira Pharma Inc
03/01/202412:00GlobeNewswire Inc.Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s DiseaseNASDAQ:ATHAAthira Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:ATHA

Your Recent History

USOTC
EDPFY
Energias De Portugal (PK)
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved